These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11827918)

  • 1. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?
    Akkerhuis KM; Alexander JH; Tardiff BE; Boersma E; Harrington RA; Lincoff AM; Simoons ML
    Circulation; 2002 Feb; 105(5):554-6. PubMed ID: 11827918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
    Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
    Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.
    Gibson CM; Murphy SA; Marble SJ; Cohen DJ; Cohen EA; Lui HK; Young J; Kitt MM; Lorenz TJ; Tcheng JE
    Am Heart J; 2002 Jan; 143(1):106-10. PubMed ID: 11773919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
    Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.
    Tardiff BE; Califf RM; Tcheng JE; Lincoff AM; Sigmon KN; Harrington RA; Mahaffey KW; Ohman EM; Teirstein PS; Blankenship JC; Kitt MM; Topol EJ
    J Am Coll Cardiol; 1999 Jan; 33(1):88-96. PubMed ID: 9935014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction.
    Jeremias A; Albirini A; Ziada KM; Chew DP; Brener SJ; Topol EJ; Ellis SG
    Am Heart J; 2002 Jun; 143(6):1040-5. PubMed ID: 12075261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.
    Brener SJ; Lytle BW; Schneider JP; Ellis SG; Topol EJ
    J Am Coll Cardiol; 2002 Dec; 40(11):1961-7. PubMed ID: 12475456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
    Alexander JH; Sparapani RA; Mahaffey KW; Deckers JW; Newby LK; Ohman EM; Corbalán R; Chierchia SL; Boland JB; Simoons ML; Califf RM; Topol EJ; Harrington RA
    JAMA; 2000 Jan; 283(3):347-53. PubMed ID: 10647797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
    Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
    J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
    Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis.
    Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Cho KI; Kim BH; Je HG; Park YH
    Catheter Cardiovasc Interv; 2013 May; 81(6):959-67. PubMed ID: 22744792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.
    Kini A; Marmur JD; Kini S; Dangas G; Cocke TP; Wallenstein S; Brown E; Ambrose JA; Sharma SK
    J Am Coll Cardiol; 1999 Sep; 34(3):663-71. PubMed ID: 10483945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes.
    Fuchs S; Gruberg L; Singh S; Stabile E; Duncan C; Wu H; Waksman R; Satler LF; Pichard AD; Kent KM; Kornowski R
    Am J Cardiol; 2001 Jul; 88(2):129-33. PubMed ID: 11448408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT--(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II Trial.
    Blankenship JC; Sigmon KN; Pieper KS; O'Shea C; Tardiff BE; Tcheng JE;
    Am J Cardiol; 2001 Nov; 88(9):969-73. PubMed ID: 11703991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy.
    Ellis SG; Chew D; Chan A; Whitlow PL; Schneider JP; Topol EJ
    Circulation; 2002 Sep; 106(10):1205-10. PubMed ID: 12208794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.